RaQualia Pharma Inc.TSE 4579

ラクオリア創薬株式会社 · Pharmaceutical · FY ends Dec

Share price at FY-end
¥1,010
FY ending Dec 2025
Market cap at FY-end
¥24.7B
Dividend per share
—
Avg. director pay
¥17.2M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 KOREA SECURITIES DEPOSITORY-SAMSUNG 2,594,100 10.61% ¥2.6B —
2 Yuichi Kakinuma 2,384,700 9.75% ¥2.4B —
3 ファイザー株式会社 743,000 3.04% ¥750M —
4 モルガン・スタンレーMUFG証券株式会社 294,807 1.21% ¥298M —
5 株式会社エス・ビー・シー 251,300 1.03% ¥254M —
6 株式会社アドバンスト・メディア 223,800 0.92% ¥226M —
7 Tokyo Tanshi Co., Ltd. 221,500 0.91% ¥224M —
8 田名後 貴裕 169,500 0.69% ¥171M —
9 香本 育良 157,000 0.64% ¥159M —
10 野村證券株式会社
Asset-management company of 野村 浩子
156,798 0.64% ¥158M —

Officers' holdings and pay

NameTitleSharesValuePay
須藤 正樹 Representative Director 30,232 ¥30.5M —
宇都 克裕 Director 19,739 ¥19.9M —
土屋 裕弘 Director — — —
石井 幸佑 Director — — —
Yuichi Kakinuma Director 2,384,700 ¥2.4B —
中野 貴之 Director — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Dec 2025 ¥1,010 ¥11.53 87.6x — 24,458,673
Source: annual securities reports on EDINET. Values are estimates. Methodology